Walleye Trading LLC Adamis Pharmaceuticals Corp Transaction History

Walleye Trading LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$2.02 - $3.22 $80,800 - $128,800	-40,000 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$2.25 - $4.8 $105,970 - $226,070	-47,098 Reduced 54.07%	40,000 $140,000
Q1 2018 May 15, 2018	SELL	$2.55 - $4.85 $15,299 - $29,099	-6,000 Reduced 6.44%	87,098 $305,000
Q4 2017 Feb 14, 2018	BUY	$3.5 - $5.65 $325,843 - $526,003	93,098	93,098 $410,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.